Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:1920-1927
Published online before print August 21, 2008, doi: 10.1161/ATVBAHA.108.169417
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
28/11/1920    most recent
ATVBAHA.108.169417v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gleissner, C. A.
Right arrow Articles by Ley, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gleissner, C. A.
Right arrow Articles by Ley, K.
Related Collections
Right arrow Chemokines in ATVB
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:1920.)
© 2008 American Heart Association, Inc.


Brief Reviews

Platelet Chemokines in Vascular Disease

Christian A. Gleissner; Philipp von Hundelshausen; Klaus Ley

From the Division of Inflammation Biology (C.A.G., K.L.), La Jolla Institute for Allergy and Immunology, Calif; and the Institute for Molecular Cardiovascular Research (IMCAR) (P.v.H.), University Hospital Aachen, Germany.

Correspondence to Klaus Ley, MD, Division of Inflammation Biology, La Jolla Institute for Allergy and Immunology, 9240 Athena Circle Drive, La Jolla, CA 92037. E-mail klaus{at}liai.org

Series Editor: Christian Weber
ATVB In Focus

Chemokines in Atherosclerosis, Thrombosis, and Vascular Biology

Platelets are a rich source of different chemokines and express chemokine receptors. CXCL4 is highly abundant in platelets and involved in promoting monocyte arrest from rolling and monocyte differentiation to macrophages. CXCL4 can also associate with CCL5 and amplify its effect on monocytes. The megakaryocyte CXCL7 gene product is proteolytically cleaved into the strong neutrophil chemoattractant, NAP-2, which has also been implicated in repair cell homing to vascular lesions. Platelet adhesion can induce release of CCL2 and CXCL8 from endothelial cells. Conversely, the chemokines CCL17, CCL22, and CXCL12 made by other cells amplify platelet activation. Platelet chemokines enhance recruitment of various hematopoietic cells to the vascular wall, fostering processes such as neointima formation, atherosclerosis, and thrombosis, but also vessel repair and regeneration after vascular injury.


Key Words: angiogenesis • atherosclerosis • platelets • thrombosis • chemokines




This article has been cited by other articles:


Home page
Diabetes CareHome page
S.-i. Araki, H. Matsuno, M. Haneda, D. Koya, Y. Kanno, J. Itho, A. Kishi, K. Isshiki, T. Sugimoto, H. Maegawa, et al.
Correlation Between Albuminuria and Spontaneous Platelet Microaggregate Formation in Type 2 Diabetic Patients
Diabetes Care, November 1, 2009; 32(11): 2062 - 2067.
[Abstract] [Full Text] [PDF]